Antibiotics

Amrubicin hydrochloride is an anthracycline chemotherapeutic agent, which is a synthetic anthracycline derivative derived from reductive amination. It functions primarily by intercalating into DNA and inhibiting topoisomerase II, an enzyme crucial to DNA replication. This mode of action disrupts DNA synthesis, leading to apoptosis in rapidly proliferating cancer cells.

Cyclosporin L is an immunosuppressive agent, which is a cyclic polypeptide derived from the soil fungus Tolypocladium inflatum. It primarily functions by inhibiting the activity of calcineurin, a key phosphatase involved in the activation of T-cells. This inhibition prevents the transcription of interleukin-2 and other cytokines critical for T-cell proliferation.

Inhibitor of protein synthesis; glycylcycline class

Thienamycin is a β-lactam antibiotic, which originates from the fermentation of the bacterium *Streptomyces cattleya*. Its mode of action involves inhibiting the synthesis of bacterial cell walls. Thienamycin accomplishes this by binding to penicillin-binding proteins (PBPs) critical for peptidoglycan construction, thereby disrupting cell wall integrity and leading to bacterial lysis.

Ionomycin is an ionophore compound with a mode of action that facilitates calcium ion transport across cell membranes. It is used in research to study calcium signaling and T-cell activation.

An aminoglycoside antibiotic.  Found applications in treatment of UTi's as it decreases the ability of bacteria to make protein.

Erythromycin lactobionate is a macrolide antibiotic, which is derived from the bacterium *Saccharopolyspora erythraea*. Its mode of action involves binding to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and leading to the suppression of bacterial growth. This mechanism effectively targets gram-positive bacteria and some gram-negative bacteria, making it a crucial agent in the fight against various bacterial infections.

Inhibitor of protein synthesis; aminoglycoside

Cefotiam is a broad-spectrum cephalosporin antibiotic, which is a beta-lactam compound derived from the mold Acremonium. It functions by inhibiting bacterial cell wall synthesis, particularly by targeting penicillin-binding proteins, which leads to cell lysis and death in susceptible bacteria. This mechanism of action makes it effective against various Gram-positive and Gram-negative bacteria.

Borrelidin is a potent antibiotic of the polyketide class, which is isolated from various Streptomyces species. Its mode of action is characterized by its inhibition of threonyl-tRNA synthetase, effectively disrupting protein synthesis within bacteria. Additionally, Borrelidin is known for its unique anti-angiogenic properties, which result from the inhibition of endothelial cell proliferation, making it a compound of interest in cancer research.

Sitafloxacin is an antibacterial agent belonging to the fluoroquinolone class of antibiotics, which is synthetically derived from chemical processes involving fluorinated quinolones. Its mode of action involves the inhibition of bacterial DNA gyrase and topoisomerase IV, enzymes crucial for bacterial DNA replication and transcription. By interfering with these enzymes, Sitafloxacin effectively hampers bacterial DNA synthesis, leading to the eventual demise of the bacterial cell.

Loracarbef monohydrate is a synthetic antibiotic, which is derived from carbacephem compounds with a mode of action that involves inhibiting bacterial cell wall synthesis. This is achieved by binding to penicillin-binding proteins, thereby blocking the cross-linking of peptidoglycan chains which are crucial for bacterial cell wall structural integrity.

Doxycycline is an antibiotic that inhibits bacterial growth by inhibiting protein synthesis, respiratory chain, DNA gyrase, DNA topoisomerase IV. Doxycycline inhibits papaverine by blocking the expression of both cytochrome P450 and epoxide hydrolase. Doxycycline is commonly found in studies for bacterial infections, drug therapy, histopathological studies, cell culture and chemometric analysis.

Vancomycin aglycon is a glycopeptide antibiotic, which is a derivative of vancomycin. It is sourced from the fermentation products of certain Amycolatopsis species, a genus of actinobacteria. The mode of action of vancomycin aglycon involves the inhibition of bacterial cell wall synthesis. It specifically binds to the D-Ala-D-Ala terminus of nascent peptidoglycan chains, thereby preventing the cross-linking that is crucial for maintaining cell wall integrity.

Piperacillin oxalylamide is an investigational antibiotic, which is a synthetic derivative of the widely used β-lactam antibiotic, piperacillin. Its development is rooted in the quest to combat β-lactamase-producing resistant bacterial strains, which are a growing threat in clinical settings. It operates by inhibiting bacterial cell wall synthesis, similar to other β-lactam antibiotics, but possesses a modified structure that enhances its resistance to enzymatic degradation by β-lactamases.

Tropodithietic acid is a bioactive compound, which is a potent antibacterial agent derived from certain marine bacteria, including the genus Phaeobacter. This antibiotic is characterized by its ability to disrupt quorum sensing, a mechanism that bacteria use for communication and coordination of group behaviors, including virulence. By interfering with this process, tropodithietic acid impedes bacterial colonization and biofilm formation, effectively inhibiting pathogenic activity.

Oligomycin A is a macrolide antibiotic, which is isolated from the Streptomyces species of bacteria. Its mode of action involves inhibiting ATP synthase by binding to the F_O subunit of the enzyme complex in the mitochondrial membrane. This binding effectively stops the flow of protons across the membrane, which is critical for ATP generation through oxidative phosphorylation.

Tridehydro pirlimycin is an antibiotic compound, which is a synthetic derivative with origins in the lincosamide family. It is characterized by its ability to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, leading to a bacteriostatic effect. The compound is primarily developed for its use in veterinary medicine, particularly in the treatment and management of bacterial infections in animals.

Lydicamycin is an antibacterial compound, which is a polyketide-derived antibiotic produced by the microorganism Streptomyces. This natural compound functions by inhibiting bacterial protein synthesis, effectively interrupting critical cellular processes within susceptible bacteria. The mode of action primarily focuses on binding to the bacterial ribosome, thereby disrupting protein production and inhibiting bacterial growth.

PC 190723 is a synthetic chemical compound, which is derived through targeted chemical synthesis processes involving precise organic reactions. Its mode of action involves disrupting cellular division by inhibiting specific protein functions essential for the mitotic process. This molecular interaction results in potent effects on cell division, making it a valuable tool for studying cellular mechanics and developing therapeutic strategies.